Moberg Pharma AB (publ) (MOBS.XC)
Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
At close: 01:48PM BST
| Previous close | 22.81 |
| Open | 25.78 |
| Bid | 26.40 x N/A |
| Ask | 25.80 x N/A |
| Day's range | 25.61 - 25.79 |
| 52-week range | 20.00 - 34.74 |
| Volume | |
| Avg. volume | 344 |
| Market cap | 746.941M |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.05 |
| Earnings date | 13 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 04 Nov 2019 |
| 1y target est | N/A |
PR NewswireMoberg Pharma has secured exercise of warrants and entered into a top guarantee free of charge
Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has today received subscription intentions, subscription commitments and top guarantee commitments totaling approximately SEK 113.5 million, related to the warrants of series 2023:1 ("TO 2"), from a few external professional investors and the Company's largest shareholder, Östersjöstiftelsen (The Baltic Sea Foundation).
PR NewswireMOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
Moberg Pharma ABs (OMX: MOB) marker partner in Sweden - Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals - has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma's medication against nail fungus.
© 2024 Yahoo. All rights reserved.